DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN
Arterial hypertension (AH) is independent risk factor of myocardial infarction, brain stroke, chronic heart failure (CHF) and hypertensive nephropathy, death from cardiovascular diseases.
Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality.
This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.
Number of Views: 313
Category of articles:
Lectures
Bibliography link
Л.К. Каражанова АНТАГОНИСТЫ КАЛЬЦИЯ ДИГИДРОПИРИДИНОВОГО РЯДА В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ: В ФОКУСЕ ЛЕРКАМЕН //НАУКА И ЗДРАВООХРАНЕНИЕ 2012.№ 2. С. 18-24 L.K. Karazhanova DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN // NAUKA I RAVOOKHRANENIE. 2012.№ 2. С. 18-24 Л.Қ. Қаражанова АРТЕРИАЛДЫ ГИПЕРТОНИЯНЫҢ ЕМІНДЕ ДИГИДРОПИРИДИН ТУЫНДЫСЫ КАЛЬЦИЙ АНТАГОНИСТЕРІ: ФОКУСТА ЛЕРКАМЕН // ҒЫЛЫМ ЖӘНЕ ДЕНСАУЛЫҚ САҚТАУ. 2012.№ 2. С. 18-24Related publications:
PAIN AND INCREASED MUSCLE TONE AFTER A STROKE AS REDUCTION FACTORS FOR REHABILITATION POTENTIAL. A MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF PATIENTS
FEATURES OF VARIOUS NEUROLOGICAL SYSTEMS DYSFUNCTION OF VASCULAR DISEASES OF THE BRAIN
DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (CHF)
CALCIUM CHANNELS BLOCKERS - A ROLE IN MODERN THERAPY OF CARDIOVASCULAR DISEASES: IN FOCUS – DILTIAZEM
DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN